Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Sodium polydeoxyribonucleotide manufacturers

4 products found

Filters

4 products found

sodium polydeoxyribonucleotide

Injection, pre-filled syringe 5.625 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #21305
The company strives for a rich and happy life by developing core source technology and applying it to overall healthcare. They are one of the global leaders in biomaterials and application. They produce cosmetic, natural products, HA Arthritis, eye drops, CL-HA filler, scaffold, PEGylation, bio-drug, and synthetic renal corpuscle.

Manufacturer usually replies in 17 days

sodium polydeoxyribonucleotide

Eye drops 0.75 mg / ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18066
It is a biopharmaceutical firm that realizes a new treatment paradigm for regenerative medicine which may be applied in various corners of life central to PDRN and PN, which are new concepts of tissue regenerating active substances. The company was founded in the 1990s and it has expanded its business area starting from consulting for drug licensing, import, and sales of innovative drugs.

sodium polydeoxyribonucleotide

Cream 0.8mg / g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18066
It is a biopharmaceutical firm that realizes a new treatment paradigm for regenerative medicine which may be applied in various corners of life central to PDRN and PN, which are new concepts of tissue regenerating active substances. The company was founded in the 1990s and it has expanded its business area starting from consulting for drug licensing, import, and sales of innovative drugs.

sodium polydeoxyribonucleotide

Ampoules, injection 5.625mg / 3 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18066
It is a biopharmaceutical firm that realizes a new treatment paradigm for regenerative medicine which may be applied in various corners of life central to PDRN and PN, which are new concepts of tissue regenerating active substances. The company was founded in the 1990s and it has expanded its business area starting from consulting for drug licensing, import, and sales of innovative drugs.